Safety and efficcacy of plasmid mediated thrombopoietin gene therapy in the treatment of thrombocytopenia secondary to chronic liver disease - Egyptian Knowledge Bank - troweb

43561

Safety and efficcacy of plasmid mediated thrombopoietin gene therapy in the treatment of thrombocytopenia secondary to chronic liver disease

Thesis

Last updated: 06 Feb 2023

Overview Similar Items

Thesis

Serum thrombopoietin level in patients with chronic liver disease

Thesis

Stem cell therapy for end stage liver disease

Thesis

Repeated autologous infusion of haematopoietic stem cells in patients with liver insufficiency

Thesis

Assessment of Gene Therapy in Egyptian Patients With Hepatocellular Carcinoma

Thesis

Autologous haematopoietic stem cell transplantation in end stage liver disease

Thesis

Hematological complications of chronic HCV infection and its treatment

Thesis

Correlation of hepatitis C viral load with the outcome of stem cell therapy in post hepatitis C cirrhotic patients

Thesis

Aetiology of anemia in chronic HCV patients receiving pegylated interferon plus ribavirin

Thesis

Assessment of health related quality of life in patients receiving stem cell therapy for end stage liver disease

Thesis

Studying the possible role of HCV genotypes and quasispecies in relation to peginterferon treatment